Report Detail

Pharma & Healthcare Global Antibody-drug Conjugates Market Professional Survey Report 2019

  • RnM2848031
  • |
  • 31 January, 2019
  • |
  • Global
  • |
  • 107 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Antibody-drug Conjugates market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Antibody-drug Conjugates volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugates market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antibody-drug Conjugates in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antibody-drug Conjugates manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ImmunoGen
Seattle Genetics
Roche
Takeda
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Adcetris
Kadcyla

Segment by Application
Breast Cancer
Lymphoma


Table of Contents

    Executive Summary

      1 Industry Overview of Antibody-drug Conjugates

      • 1.1 Definition of Antibody-drug Conjugates
      • 1.2 Antibody-drug Conjugates Segment by Type
        • 1.2.1 Global Antibody-drug Conjugates Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Adcetris
        • 1.2.3 Kadcyla
      • 1.3 Antibody-drug Conjugates Segment by Applications
        • 1.3.1 Global Antibody-drug Conjugates Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Breast Cancer
        • 1.3.3 Lymphoma
      • 1.4 Global Antibody-drug Conjugates Overall Market
        • 1.4.1 Global Antibody-drug Conjugates Revenue (2014-2025)
        • 1.4.2 Global Antibody-drug Conjugates Production (2014-2025)
        • 1.4.3 North America Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.4 Europe Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.5 China Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.6 Japan Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.8 India Antibody-drug Conjugates Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Antibody-drug Conjugates
      • 2.3 Manufacturing Process Analysis of Antibody-drug Conjugates
      • 2.4 Industry Chain Structure of Antibody-drug Conjugates

      3 Development and Manufacturing Plants Analysis of Antibody-drug Conjugates

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Antibody-drug Conjugates Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Antibody-drug Conjugates
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Antibody-drug Conjugates Production and Capacity Analysis
      • 4.2 Antibody-drug Conjugates Revenue Analysis
      • 4.3 Antibody-drug Conjugates Price Analysis
      • 4.4 Market Concentration Degree

      5 Antibody-drug Conjugates Regional Market Analysis

      • 5.1 Antibody-drug Conjugates Production by Regions
        • 5.1.1 Global Antibody-drug Conjugates Production by Regions
        • 5.1.2 Global Antibody-drug Conjugates Revenue by Regions
      • 5.2 Antibody-drug Conjugates Consumption by Regions
      • 5.3 North America Antibody-drug Conjugates Market Analysis
        • 5.3.1 North America Antibody-drug Conjugates Production
        • 5.3.2 North America Antibody-drug Conjugates Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Antibody-drug Conjugates Import and Export
      • 5.4 Europe Antibody-drug Conjugates Market Analysis
        • 5.4.1 Europe Antibody-drug Conjugates Production
        • 5.4.2 Europe Antibody-drug Conjugates Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Antibody-drug Conjugates Import and Export
      • 5.5 China Antibody-drug Conjugates Market Analysis
        • 5.5.1 China Antibody-drug Conjugates Production
        • 5.5.2 China Antibody-drug Conjugates Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Antibody-drug Conjugates Import and Export
      • 5.6 Japan Antibody-drug Conjugates Market Analysis
        • 5.6.1 Japan Antibody-drug Conjugates Production
        • 5.6.2 Japan Antibody-drug Conjugates Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Antibody-drug Conjugates Import and Export
      • 5.7 Southeast Asia Antibody-drug Conjugates Market Analysis
        • 5.7.1 Southeast Asia Antibody-drug Conjugates Production
        • 5.7.2 Southeast Asia Antibody-drug Conjugates Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Antibody-drug Conjugates Import and Export
      • 5.8 India Antibody-drug Conjugates Market Analysis
        • 5.8.1 India Antibody-drug Conjugates Production
        • 5.8.2 India Antibody-drug Conjugates Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Antibody-drug Conjugates Import and Export

      6 Antibody-drug Conjugates Segment Market Analysis (by Type)

      • 6.1 Global Antibody-drug Conjugates Production by Type
      • 6.2 Global Antibody-drug Conjugates Revenue by Type
      • 6.3 Antibody-drug Conjugates Price by Type

      7 Antibody-drug Conjugates Segment Market Analysis (by Application)

      • 7.1 Global Antibody-drug Conjugates Consumption by Application
      • 7.2 Global Antibody-drug Conjugates Consumption Market Share by Application (2014-2019)

      8 Antibody-drug Conjugates Major Manufacturers Analysis

      • 8.1 ImmunoGen
        • 8.1.1 ImmunoGen Antibody-drug Conjugates Production Sites and Area Served
        • 8.1.2 ImmunoGen Product Introduction, Application and Specification
        • 8.1.3 ImmunoGen Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Seattle Genetics
        • 8.2.1 Seattle Genetics Antibody-drug Conjugates Production Sites and Area Served
        • 8.2.2 Seattle Genetics Product Introduction, Application and Specification
        • 8.2.3 Seattle Genetics Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Roche
        • 8.3.1 Roche Antibody-drug Conjugates Production Sites and Area Served
        • 8.3.2 Roche Product Introduction, Application and Specification
        • 8.3.3 Roche Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Takeda
        • 8.4.1 Takeda Antibody-drug Conjugates Production Sites and Area Served
        • 8.4.2 Takeda Product Introduction, Application and Specification
        • 8.4.3 Takeda Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served

      9 Development Trend of Analysis of Antibody-drug Conjugates Market

      • 9.1 Global Antibody-drug Conjugates Market Trend Analysis
        • 9.1.1 Global Antibody-drug Conjugates Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Antibody-drug Conjugates Regional Market Trend
        • 9.2.1 North America Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.2 Europe Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.3 China Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.4 Japan Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.5 Southeast Asia Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.6 India Antibody-drug Conjugates Forecast 2019-2025
      • 9.3 Antibody-drug Conjugates Market Trend (Product Type)
      • 9.4 Antibody-drug Conjugates Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Antibody-drug Conjugates Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Antibody-drug Conjugates . Industry analysis & Market Report on Antibody-drug Conjugates is a syndicated market report, published as Global Antibody-drug Conjugates Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Antibody-drug Conjugates market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,796.50
        4,194.75
        5,593.00
        3,248.00
        4,872.00
        6,496.00
        545,510.00
        818,265.00
        1,091,020.00
        292,495.00
        438,742.50
        584,990.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report